Program in Membrane Biology and Nephrology Division, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114 USA.
Department of Nephrology, Tokyo Medical and Dental University, Tokyo 113-8519, Japan.
Cells. 2020 Apr 23;9(4):1057. doi: 10.3390/cells9041057.
We previously showed that in polarized Madin-Darby canine kidney (MDCK) cells, aquaporin-2 (AQP2) is continuously targeted to the basolateral plasma membrane from which it is rapidly retrieved by clathrin-mediated endocytosis. It then undertakes microtubule-dependent transcytosis toward the apical plasma membrane. In this study, we found that treatment with chlorpromazine (CPZ, an inhibitor of clathrin-mediated endocytosis) results in AQP2 accumulation in the basolateral, but not the apical plasma membrane of epithelial cells. In MDCK cells, both AQP2 and clathrin were concentrated in the basolateral plasma membrane after CPZ treatment (100 µM for 15 min), and endocytosis was reduced. Then, using rhodamine phalloidin staining, we found that basolateral, but not apical, F-actin was selectively reduced by CPZ treatment. After incubation of rat kidney slices in situ with CPZ (200 µM for 15 min), basolateral AQP2 and clathrin were increased in principal cells, which simultaneously showed a significant decrease of basolateral compared to apical F-actin staining. These results indicate that clathrin-dependent transcytosis of AQP2 is an essential part of its trafficking pathway in renal epithelial cells and that this process can be inhibited by selectively depolymerizing the basolateral actin pool using CPZ.
我们之前曾表明,在极化的犬肾(MDCK)细胞中,水通道蛋白-2(AQP2)从基底面质膜连续靶向,从质膜快速通过网格蛋白介导的内吞作用回收。然后,它进行微管依赖性跨细胞转运到顶质膜。在这项研究中,我们发现用氯丙嗪(CPZ,网格蛋白介导的内吞作用抑制剂)处理会导致 AQP2 在基底面质膜中积累,但不在上皮细胞的顶质膜中积累。在 MDCK 细胞中,CPZ 处理(15 分钟,100µM)后,AQP2 和网格蛋白都集中在基底面质膜中,内吞作用减少。然后,通过使用罗丹明鬼笔环肽染色,我们发现 CPZ 处理选择性地减少了基底面质膜,而不是顶质膜中的 F-肌动蛋白。在用 CPZ(200µM,15 分钟)原位孵育大鼠肾切片后,主细胞中基底面质膜中的 AQP2 和网格蛋白增加,同时基底面质膜相对于顶质膜 F-肌动蛋白染色明显减少。这些结果表明,AQP2 的网格蛋白依赖的转胞吞作用是其在肾上皮细胞中的运输途径的重要组成部分,并且该过程可以通过使用 CPZ 选择性地解聚基底面质膜中的肌动蛋白池来抑制。